ストックスクリーナーアプリを入手
54.55
0.87%
0.47
アフターアワーズ：
54.55
前日終値:
$54.08
開ける：
$53.89
24時間の取引高:
2.42M
Relative Volume:
0.93
時価総額：
$13.52B
収益：
$2.38B
当期純損益:
$833.42M
株価収益率:
18.08
EPS:
3.0172
ネットキャッシュフロー:
$917.69M
1週間 パフォーマンス:
+4.26%
1か月 パフォーマンス:
-1.48%
6か月 パフォーマンス:
+20.85%
1年 パフォーマンス:
+41.21%
1日の値動き範囲:
$53.39
$54.79
1週間の範囲:
$52.11
$54.79
52週間の値動き範囲:
$33.76
$57.57
Exelixis Inc Stock (EXEL) Company Profile
Compare EXEL vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EXEL
Exelixis Inc
|
54.55 | 13.30B | 2.38B | 833.42M | 917.69M | 3.0172 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Exelixis Inc Stock (EXEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-08 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2026-01-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2025-11-18 | 開始されました | Wolfe Research | Peer Perform |
| 2025-11-03 | ダウングレード | Guggenheim | Buy → Neutral |
| 2025-10-21 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-09-19 | 再開されました | Barclays | Equal Weight |
| 2025-09-17 | 再開されました | Barclays | Equal Weight |
| 2025-09-17 | 開始されました | Goldman | Buy |
| 2025-07-08 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-06-24 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2025-02-24 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-01-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-01-24 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-12-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-17 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-10-16 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2024-09-19 | 開始されました | UBS | Neutral |
| 2024-04-11 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2023-12-19 | 開始されました | BTIG Research | Buy |
| 2023-12-15 | 開始されました | Citigroup | Buy |
| 2023-09-26 | 開始されました | H.C. Wainwright | Buy |
| 2023-08-22 | 繰り返されました | Oppenheimer | Outperform |
| 2023-08-08 | 開始されました | SVB Securities | Market Perform |
| 2023-07-11 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-05-10 | 再開されました | Piper Sandler | Overweight |
| 2023-03-09 | 開始されました | Wells Fargo | Overweight |
| 2023-01-26 | 開始されました | Credit Suisse | Outperform |
| 2022-10-18 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-06-24 | 開始されました | BMO Capital Markets | Outperform |
| 2021-11-19 | 開始されました | Piper Sandler | Overweight |
| 2021-11-03 | 再開されました | Jefferies | Buy |
| 2021-10-07 | 開始されました | Jefferies | Buy |
| 2021-08-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2021-06-15 | 開始されました | H.C. Wainwright | Buy |
| 2021-05-18 | 再開されました | Goldman | Sell |
| 2021-03-31 | 開始されました | Credit Suisse | Outperform |
| 2021-03-12 | 開始されました | Wolfe Research | Outperform |
| 2020-03-04 | 開始されました | Barclays | Overweight |
| 2020-01-13 | 開始されました | SunTrust | Buy |
| 2019-11-13 | 開始されました | BofA/Merrill | Buy |
| 2019-03-18 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2018-09-17 | 開始されました | Goldman | Neutral |
| 2018-09-10 | 開始されました | Morgan Stanley | Underweight |
| 2018-05-11 | 繰り返されました | Needham | Buy |
| 2017-10-17 | 繰り返されました | Needham | Buy |
| 2017-10-17 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-10-16 | 繰り返されました | SunTrust | Buy |
| 2017-09-22 | ダウングレード | Leerink Partners | Outperform → Mkt Perform |
| 2017-09-15 | 開始されました | RBC Capital Mkts | Outperform |
| 2017-09-12 | 繰り返されました | Needham | Buy |
| 2017-07-14 | 開始されました | SunTrust | Buy |
| 2017-03-31 | 開始されました | Needham | Buy |
| 2017-03-16 | 開始されました | Oppenheimer | Perform |
| 2017-02-28 | ダウングレード | Stifel | Buy → Hold |
| 2016-11-03 | 開始されました | Deutsche Bank | Buy |
| 2016-10-10 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2016-09-15 | 繰り返されました | Stifel | Buy |
すべてを表示
Exelixis Inc (EXEL) 最新ニュース
NFJ Investment Group LLC Makes New $18.39 Million Investment in Exelixis, Inc. $EXEL - MarketBeat
51,642 Shares in Exelixis, Inc. $EXEL Purchased by NewEdge Wealth LLC - MarketBeat
BlackRock Inc. Purchases New Stake in Exelixis, Inc. $EXEL - MarketBeat
EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with SBS Law - The Daily Tribune News
FARALLON CAPITAL MANAGEMENT, L.L.C. Buys More Exelixis Inc (EXEL - GuruFocus
BMO Capital Markets Upgrades Exelixis (NASDAQ:EXEL) to "Hold" - MarketBeat
Abacus FCF Advisors LLC Invests $7.29 Million in Exelixis, Inc. $EXEL - MarketBeat
Out of sight, out of work? What’s driving remote job cuts - BioSpace
Investigation launched into EXELIXIS officers f... - Pluang
Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm - PR Newswire
Exelixis Inc : BMO Initiates Coverage With Ma - Moomoo
EXELIXIS INC : BMO INITIATES COVERAGE WITH MARKET PERFORM RATING; PRICE TARGET $54 - Bitget
BMO initiates Exelixis stock at Market Perform, cites patent cliff By Investing.com - Investing.com Australia
EXEL Initiates Coverage On BMO Capital -- Price Target Announced at $54.00 - GuruFocus
BMO initiates Exelixis stock at Market Perform, cites patent cliff - Investing.com
JLB & Associates Inc. Acquires Shares of 48,849 Exelixis, Inc. $EXEL - MarketBeat
Exelixis Inc (EXEL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AQR Capital Management Trims Exelixis Inc (EXEL) Stake -- Shares Trade 16% Above GF Value - GuruFocus
EXEL Looks 16.3% Overvalued on GF Value™ - GuruFocus
Pallas Capital Advisors LLC Invests $1.67 Million in Exelixis, Inc. $EXEL - MarketBeat
27,109 Shares in Exelixis, Inc. $EXEL Purchased by Grandfield & Dodd LLC - MarketBeat
Exelixis (EXEL) Climbs 2.48% as Shares Test Key Resistance at $55.14ATR Stop - vinanet.vn
Exelixis (EXEL) Securities Investigation NoticeLevi & Korsinsky - PR Newswire
Exelixis, Inc. (EXEL) Stock Analysis: Evaluating the 3.31% Upside with Strong Revenue Growth - DirectorsTalk Interviews
Focus Partners Advisor Solutions LLC Buys Shares of 26,603 Exelixis, Inc. $EXEL - MarketBeat
Exelixis (MIC:EXEL-RM) EV-to-OCF : 0.00 (As of Aug. 16, 2026) - GuruFocus
Exelixis (EXEL) Is Down 5.2% After Raising Q2 Profitability And Trimming 2026 Revenue Outlook – Has The Bull Case Changed? - Sahm
EXEL|Exelixis Inc|Price:50.990| - TradingKey
Farallon Capital (EXEL) discloses 13.99M-share Exelixis stake at $308M cost - Stock Titan
EXEL|Exelixis Inc|Price:52.360|Chg%:+1.120 - TradingKey
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Exelixis (EXEL) - GlobeNewswire
Exelixis Inc (EXEL) Director Mary Beckerle Sells 9,812 Shares - GuruFocus
Annex Advisory Services LLC Makes New Investment in Exelixis, Inc. $EXEL - MarketBeat
Exelixis, Inc. (EXEL) Stock Forecasts - Yahoo! Finance Canada
Exelixis director Mary Beckerle sells $526k in shares - Investing.com
Exelixis director Mary Beckerle sells $526k in shares By Investing.com - Investing.com South Africa
Insider Selling: Exelixis (NASDAQ:EXEL) Director Sells $526,511.92 in Stock - MarketBeat
Exelixis (EXEL) Q2 2026 Earnings Call Transcript - The Globe and Mail
Exelixis (EXEL) director Beckerle sells 9,812 shares via Rule 10b5-1 plan - Stock Titan
EXEL Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Exelixis (EXEL) - Business Wire
AQR Capital discloses 11.0M-share Exelixis (EXEL) position at 4.39% ownership - Stock Titan
EXEL SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Exelixis - PR Newswire
Exelixis Inc (EXEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Exelixis Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Exelixis (EXEL) - PR Newswire
EXELIXIS, INC. SEC Filing (Aug 10, 2026) - stocktitan.net
Exelixis, Inc. (EXEL) Stock Analysis: Exploring Growth Potential in Oncology with a Strong ROE - DirectorsTalk Interviews
Bank of America Corp DE Sells 578,181 Shares of Exelixis, Inc. $EXEL - MarketBeat
Exelixis, Inc. $EXEL Shares Acquired by Assenagon Asset Management S.A. - MarketBeat
EXELIXIS INCDRN (E2XE34.SA) Q1 FY2026 earnings call transcript - Yahoo Finance
Amundi Sells 121,348 Shares of Exelixis, Inc. $EXEL - MarketBeat
Exelixis (NASDAQ:EXEL) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat
Exelixis Inc (EXEL) 財務データ
収益
当期純利益
現金流量
EPS
0.00%
3.22%
大文字化:
|
ボリューム (24 時間):